Please Wait.....
Report
Testosterone Replacement Therapy Market By Product Type (Injectables, Topical, Others), By Active ingredients (Testosterone Cypionate, Testosterone, Testosterone Enanthate, Testosterone Undecanoate, Others), By End User (Hospital, Clinics): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2024-03-01 I 270 Pages I Allied Market Research
The global testosterone replacement therapy market was valued at $1.9 billion in 2022, and is projected to reach $2.9 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2032.
Testosterone replacement therapy is a medical intervention designed to address low levels of testosterone. Testosterone is a crucial hormone responsible for the development of male reproductive tissues and the maintenance of male characteristics, such as muscle mass, bone density, and facial hair. As men age, testosterone levels tend to decline naturally, leading to various symptoms such as fatigue, reduced libido, and loss of muscle mass. Testosterone replacement therapy involves the administration of exogenous testosterone through methods such as injections, patches, gels, or pellets implanted under the skin. The goal is to restore testosterone levels to a normal range and alleviate associated symptoms.
The testosterone replacement therapy market growth is attributed rise in prevalence of hypogonadism and the rising incidence of chronic diseases such as obesity, diabetes, and metabolic syndrome, which are associated with an increased risk of low testosterone levels. The prevalence of hypogonadism has witnessed a notable rise in recent years, emerging as a significant driver for the growth of testosterone replacement therapy market. Hypogonadism, characterized by the insufficient production of testosterone in the testes, affects a considerable portion of the male population, particularly as they age. For instance, according to 2021 report by National Library of Medicine, it was estimated that the prevalence of hypogonadism in middle-aged and older men varies between 2.1% and 38.7%. Testosterone replacement therapy has become a primary choice for healthcare professionals in addressing the hormonal imbalances associated with hypogonadism. Thus, a rise in prevalence of hypogonadism is expected to drive the growth of the market.
In addition, rise in incidence of chronic diseases such as obesity and diabetes which causes low testosterone is expected to drive the market growth. Chronic diseases, including diabetes, obesity, and cardiovascular ailments, have become increasingly prevalent worldwide, contributing to a surge in individuals experiencing hormonal imbalances, particularly low testosterone levels. Scientific studies have established a direct correlation between chronic illnesses and reduced testosterone production, creating a substantial patient pool seeking effective therapeutic interventions to treat low testosterone levels. According to 2023 report by National Library of Medicine, it was reported that male obesity is linked to hormonal disturbances leading to impaired gonadal functions, both hormonal and reproductive. Male obesity-related hypogonadism has been reported in up to 45% of patients with moderate to severe obesity. Thus, rise in incidence of chronic diseases, such as obesity and diabetes, is expected to drive the growth of the testosterone replacement therapy market. However, side effects associated with the chemical peels and photo therapy restrain the growth of the market. According to the 2023 report by American College of Cardiology Foundation, it was reported that the incidence of pulmonary embolism, nonfatal arrhythmia, atrial fibrillation, and acute injury was higher in subjects who received testosterone replacement therapy.
The testosterone replacement therapy market is segmented on the basis of product type, active ingredient, end user, and region. By product type, the market is classified into injectables, topical, and others. Other product types include oral, implant, and intranasal formulations. By active ingredient, the market is divided into testosterone cypionate, testosterone, testosterone enanthate, testosterone undecanoate, others. By end user, it is segregated into hospitals, and clinics. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).
Major key players that operate in the testosterone replacement therapy market are AbbVie Inc, Besins Healthcare SA, Acerus Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Acrux Ltd., Endo International Plc, Biote Medical, LLC, Pfizer Inc., Insud Pharma S.L, and Marius Pharmaceuticals. Key players have adopted acquisition as a key developmental strategy to improve the product portfolio of the testosterone replacement therapy market
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the testosterone replacement therapy market analysis from 2022 to 2032 to identify the prevailing testosterone replacement therapy market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the testosterone replacement therapy market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global testosterone replacement therapy market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product Type
- Injectables
- Topical
- Others
By Active ingredients
- Testosterone Undecanoate
- Others
- Testosterone Cypionate
- Testosterone
- Testosterone Enanthate
By End User
- Hospital
- Clinics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Colombia
- Argentina
- Rest of Latin America
- Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea
- Key Market Players
- AbbVie Inc.
- Besins Healthcare SA
- Acerus Pharmaceuticals Corporation
- Amneal Pharmaceuticals Inc.
- Acrux Ltd.
- Endo International plc.
- Biote Medical LLC
- Insud Pharma S.L
- Marius Pharmaceuticals
- Pfizer Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Injectables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Topical
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Others
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS
5.1. Overview
5.1.1. Market size and forecast
5.2. Testosterone Cypionate
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Testosterone
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Testosterone Enanthate
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Testosterone Undecanoate
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Active ingredients
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Active ingredients
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Active ingredients
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Active ingredients
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Active ingredients
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Active ingredients
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Active ingredients
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Active ingredients
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Active ingredients
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Active ingredients
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Active ingredients
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Active ingredients
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Active ingredients
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Active ingredients
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Active ingredients
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Active ingredients
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Active ingredients
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Active ingredients
7.4.5.6.3. Market size and forecast, by End User
7.5. Latin America
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Active ingredients
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Active ingredients
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Colombia
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Active ingredients
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Argentina
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Active ingredients
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of Latin America
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Active ingredients
7.5.5.4.3. Market size and forecast, by End User
7.6. Middle East and Africa
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market size and forecast, by Product Type
7.6.3. Market size and forecast, by Active ingredients
7.6.4. Market size and forecast, by End User
7.6.5. Market size and forecast, by country
7.6.5.1. Gcc
7.6.5.1.1. Market size and forecast, by Product Type
7.6.5.1.2. Market size and forecast, by Active ingredients
7.6.5.1.3. Market size and forecast, by End User
7.6.5.2. South Africa
7.6.5.2.1. Market size and forecast, by Product Type
7.6.5.2.2. Market size and forecast, by Active ingredients
7.6.5.2.3. Market size and forecast, by End User
7.6.5.3. North Africa
7.6.5.3.1. Market size and forecast, by Product Type
7.6.5.3.2. Market size and forecast, by Active ingredients
7.6.5.3.3. Market size and forecast, by End User
7.6.5.4. Rest Of Mea
7.6.5.4.1. Market size and forecast, by Product Type
7.6.5.4.2. Market size and forecast, by Active ingredients
7.6.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. AbbVie Inc.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Besins Healthcare SA
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Acerus Pharmaceuticals Corporation
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Amneal Pharmaceuticals Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Acrux Ltd.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Endo International plc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Biote Medical LLC
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Insud Pharma S.L
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Marius Pharmaceuticals
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Pfizer Inc.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR INJECTABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TOPICAL, BY REGION, 2022-2032 ($MILLION)
TABLE 04. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 06. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE CYPIONATE, BY REGION, 2022-2032 ($MILLION)
TABLE 07. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE ENANTHATE, BY REGION, 2022-2032 ($MILLION)
TABLE 09. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE UNDECANOATE, BY REGION, 2022-2032 ($MILLION)
TABLE 10. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)
TABLE 13. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 19. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 20. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 21. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 22. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 23. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 24. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 25. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 26. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 27. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 28. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 29. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 30. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 31. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 32. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 33. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 34. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 35. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 36. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 37. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 39. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 40. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 41. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 42. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 43. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 44. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 45. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 46. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 54. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 55. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 56. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 58. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 59. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 60. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 61. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 62. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 72. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 73. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 74. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 76. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 77. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 78. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 80. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 81. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 82. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 83. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 84. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 85. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 86. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 87. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 88. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 89. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 90. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 91. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 92. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 93. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 94. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 95. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 96. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 97. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 98. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 99. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 100. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 101. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 102. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
TABLE 103. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. ABBVIE INC.: KEY EXECUTIVES
TABLE 105. ABBVIE INC.: COMPANY SNAPSHOT
TABLE 106. ABBVIE INC.: PRODUCT SEGMENTS
TABLE 107. ABBVIE INC.: SERVICE SEGMENTS
TABLE 108. ABBVIE INC.: PRODUCT PORTFOLIO
TABLE 109. ABBVIE INC.: KEY STRATERGIES
TABLE 110. BESINS HEALTHCARE SA: KEY EXECUTIVES
TABLE 111. BESINS HEALTHCARE SA: COMPANY SNAPSHOT
TABLE 112. BESINS HEALTHCARE SA: PRODUCT SEGMENTS
TABLE 113. BESINS HEALTHCARE SA: SERVICE SEGMENTS
TABLE 114. BESINS HEALTHCARE SA: PRODUCT PORTFOLIO
TABLE 115. BESINS HEALTHCARE SA: KEY STRATERGIES
TABLE 116. ACERUS PHARMACEUTICALS CORPORATION: KEY EXECUTIVES
TABLE 117. ACERUS PHARMACEUTICALS CORPORATION: COMPANY SNAPSHOT
TABLE 118. ACERUS PHARMACEUTICALS CORPORATION: PRODUCT SEGMENTS
TABLE 119. ACERUS PHARMACEUTICALS CORPORATION: SERVICE SEGMENTS
TABLE 120. ACERUS PHARMACEUTICALS CORPORATION: PRODUCT PORTFOLIO
TABLE 121. ACERUS PHARMACEUTICALS CORPORATION: KEY STRATERGIES
TABLE 122. AMNEAL PHARMACEUTICALS INC.: KEY EXECUTIVES
TABLE 123. AMNEAL PHARMACEUTICALS INC.: COMPANY SNAPSHOT
TABLE 124. AMNEAL PHARMACEUTICALS INC.: PRODUCT SEGMENTS
TABLE 125. AMNEAL PHARMACEUTICALS INC.: SERVICE SEGMENTS
TABLE 126. AMNEAL PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
TABLE 127. AMNEAL PHARMACEUTICALS INC.: KEY STRATERGIES
TABLE 128. ACRUX LTD.: KEY EXECUTIVES
TABLE 129. ACRUX LTD.: COMPANY SNAPSHOT
TABLE 130. ACRUX LTD.: PRODUCT SEGMENTS
TABLE 131. ACRUX LTD.: SERVICE SEGMENTS
TABLE 132. ACRUX LTD.: PRODUCT PORTFOLIO
TABLE 133. ACRUX LTD.: KEY STRATERGIES
TABLE 134. ENDO INTERNATIONAL PLC.: KEY EXECUTIVES
TABLE 135. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
TABLE 136. ENDO INTERNATIONAL PLC.: PRODUCT SEGMENTS
TABLE 137. ENDO INTERNATIONAL PLC.: SERVICE SEGMENTS
TABLE 138. ENDO INTERNATIONAL PLC.: PRODUCT PORTFOLIO
TABLE 139. ENDO INTERNATIONAL PLC.: KEY STRATERGIES
TABLE 140. BIOTE MEDICAL LLC: KEY EXECUTIVES
TABLE 141. BIOTE MEDICAL LLC: COMPANY SNAPSHOT
TABLE 142. BIOTE MEDICAL LLC: PRODUCT SEGMENTS
TABLE 143. BIOTE MEDICAL LLC: SERVICE SEGMENTS
TABLE 144. BIOTE MEDICAL LLC: PRODUCT PORTFOLIO
TABLE 145. BIOTE MEDICAL LLC: KEY STRATERGIES
TABLE 146. INSUD PHARMA S.L: KEY EXECUTIVES
TABLE 147. INSUD PHARMA S.L: COMPANY SNAPSHOT
TABLE 148. INSUD PHARMA S.L: PRODUCT SEGMENTS
TABLE 149. INSUD PHARMA S.L: SERVICE SEGMENTS
TABLE 150. INSUD PHARMA S.L: PRODUCT PORTFOLIO
TABLE 151. INSUD PHARMA S.L: KEY STRATERGIES
TABLE 152. MARIUS PHARMACEUTICALS: KEY EXECUTIVES
TABLE 153. MARIUS PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 154. MARIUS PHARMACEUTICALS: PRODUCT SEGMENTS
TABLE 155. MARIUS PHARMACEUTICALS: SERVICE SEGMENTS
TABLE 156. MARIUS PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 157. MARIUS PHARMACEUTICALS: KEY STRATERGIES
TABLE 158. PFIZER INC.: KEY EXECUTIVES
TABLE 159. PFIZER INC.: COMPANY SNAPSHOT
TABLE 160. PFIZER INC.: PRODUCT SEGMENTS
TABLE 161. PFIZER INC.: SERVICE SEGMENTS
TABLE 162. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 163. PFIZER INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF TESTOSTERONE REPLACEMENT THERAPY MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN TESTOSTERONE REPLACEMENT THERAPY MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN TESTOSTERONE REPLACEMENT THERAPY MARKET (2023-2032)
FIGURE 05. BARGAINING POWER OF SUPPLIERS
FIGURE 06. BARGAINING POWER OF BUYERS
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. THREAT OF SUBSTITUTION
FIGURE 09. COMPETITIVE RIVALRY
FIGURE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR INJECTABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TOPICAL, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE CYPIONATE, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE ENANTHATE, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE UNDECANOATE, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR HOSPITAL, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR CLINICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. TESTOSTERONE REPLACEMENT THERAPY MARKET BY REGION, 2022 AND 2032(%)
FIGURE 25. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 26. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 27. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 28. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 29. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 30. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 31. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 32. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 33. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 34. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 35. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 36. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 37. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 38. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 40. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 41. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 42. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 43. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 44. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 45. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 46. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 47. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52. COMPETITIVE DASHBOARD
FIGURE 53. COMPETITIVE HEATMAP: TESTOSTERONE REPLACEMENT THERAPY MARKET
FIGURE 54. TOP PLAYER POSITIONING, 2022
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security